The number and percentages of swollen joints at baseline, and after 12 and 24 weeks of treatment as a function of the scintigraphic status at baseline
| All patients | Scintigraphic negative | Scintigraphic positive | OR | p Value | ||||
|---|---|---|---|---|---|---|---|---|
| No swelling | Swelling | No swelling | Swelling | |||||
| Swollen joints at baseline | 1059 (98.3%) | 18 (1.7%) | 104 (62.3%) | 63 (37.7%) | 36.85 | <0.001 | ||
| Not swollen anymore at w12 or w24 | Remains swollen at w12 or w24 | Not swollen anymore at w12 or w24 | Remains swollen at w12 or w24 | |||||
| Swollen joints at w12 | 18 | 0 | 56 (88.9%) | 7 (11.1%) | * | 0.339 | ||
| Swollen joints at w24 | 18 | 0 | 58 (92.1%) | 5 (7.9%) | * | 0.581 | ||
The OR refers to the odds of a joint being tender and/or swollen in the scintigraphic-positive as compared with the scintigraphic-negative group. For all tests, p values <0.05 are considered to indicate statistical significance.
*ORs for swollen joint count could not be estimated due to the fact that one cell, that is, scintigraphic-negative symptom has frequency zero.
w12, week 12; w24, week 24.